FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to dermatology, and can be used for medical purposes for studying pathogenesis of disease and action of external drug preparations. Method of forming a laboratory model of psoriasis in imiquimod-induced inflammation in experimental animals involves external application of imiquimod once day by 62.5 mg for 10 days on pre-shaved skin of back of Balb/c mice 7–8 weeks.
EFFECT: invention provides more indicative and reproducible model of psoriasis on laboratory animals.
1 cl, 2 ex, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR FORMING EXPERIMENTAL MODEL OF CHRONIC IMIQUIMOD-INDUCED PSORIASIS-LIKE DERMATITIS IN MICE | 2023 |
|
RU2820279C1 |
| METHOD FOR EVALUATING THE ANTIPSORIATIC EFFECT OF AN EXTERNAL AGENT ON A LABORATORY MODEL OF IMIQUIMOD-INDUCED PSORIASIS | 2021 |
|
RU2764549C1 |
| PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PSORIASIS | 2020 |
|
RU2742879C1 |
| METHOD FOR EVALUATING EFFECTIVENESS OF THERAPY IN VITRO AND IN VIVO IN EXPERIMENTAL MODEL OF IMIQUIMOD-INDUCED PSORIASIS-LIKE DERMATITIS | 2023 |
|
RU2829630C1 |
| CREAM WITH SECRETORY OF MULTIPOTENT MESENCHYMAL STROMAL CELLS FOR CORRECTION OF PSORIASIFORM INFLAMMATION IN EXPERIMENT | 2019 |
|
RU2704322C1 |
| PHARMACEUTICAL COMPOSITION HAVING THERAPEUTIC EFFECT IN VARIOUS SKIN PATHOLOGIES | 2019 |
|
RU2694059C1 |
| MEANS FOR THE TREATMENT OF ATOPIC DERMATITIS | 2022 |
|
RU2794841C1 |
| METHOD OF TREATMENT OF ROSACEA | 2020 |
|
RU2811956C2 |
| DRUG FOR TREATMENT OF PSORIASIS AND ITS PRODUCTION METHOD | 2019 |
|
RU2785038C2 |
| COMPOSITIONS CONTAINING BERBERINE OR ITS ANALOGUES FOR TREATING SKIN DISEASES RELATED TO ROSACEA OR BLUSH | 2010 |
|
RU2533458C2 |
